Sino Biopharmaceutical co-led the oncology treatment developer's latest round, in which it raised over $91m in funding.

IP Group returned for the Bristol spinout's series D that will go to product development and commercialisation.

Bringing together researchers from Italy and the US, Chroma Medicine has emerged out of stealth with series A financing led by Cormorant Asset Management.

The neuromodulation-focused Stanford spinout increased its overall funding to $145m in a round led by Ascension Ventures.

Kindred Ventures led the healthcare services provider's series E round, valuing it at $4.6bn.

UTEC is celebrating an exit as Agara is acquired by Coinbase for a reported $40m to $50m.

Johns Hopkins spinout Blade Therapeutics has agreed to a reverse merger that will net it $24.3m in Pipe financing from backers including Osage University Partners.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The Ohio State spinout has gone public in an upsized IPO sized at approximately $182m.

BMW, Continental, Knorr-Bremse and VinFast backed the autonomous perception technology developer, which traces its roots to Technion.